Taro-Docusate Capsules USP 100 mg (2014-04-25)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 230000505 | Taro-Docusate Capsules USP 100 mg | - Recalling Firm
- Taro Pharmaceuticals Inc.
- 130 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Taro Pharmaceuticals Inc.
- 130 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| Capsule | DIN 00716731 | 100 mg |
Recalled products
Taro-Docusate Capsules USP 100 mg
Foreign matter identified as inert nitrile rubber was found in a capsule.
Retailers in all provinces and territories except Yukon, Northwest Territories, Nunavut, and Prince Edward Island.